Literature DB >> 29670249

The Relationship Between Dopamine Synthesis Capacity and Release: Implications for Psychosis.

Matthew M Nour1, Robert McCutcheon1, Oliver D Howes1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29670249      PMCID： PMC5916363          DOI： 10.1038/npp.2017.293

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  9 in total

1.  Endogenous dopamine release after pharmacological challenges in Parkinson's disease.

Authors:  Paola Piccini; Nicola Pavese; David J Brooks
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

Review 2.  An Integrative Perspective on the Role of Dopamine in Schizophrenia.

Authors:  Tiago V Maia; Michael J Frank
Journal:  Biol Psychiatry       Date:  2016-06-01       Impact factor: 13.382

3.  Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.

Authors:  A Abi-Dargham; R Gil; J Krystal; R M Baldwin; J P Seibyl; M Bowers; C H van Dyck; D S Charney; R B Innis; M Laruelle
Journal:  Am J Psychiatry       Date:  1998-06       Impact factor: 18.112

4.  Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids.

Authors:  Dan P Covey; Kendra D Bunner; Douglas R Schuweiler; Joseph F Cheer; Paul A Garris
Journal:  Eur J Neurosci       Date:  2016-05-11       Impact factor: 3.386

5.  Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals.

Authors:  D P Daberkow; H D Brown; K D Bunner; S A Kraniotis; M A Doellman; M E Ragozzino; P A Garris; M F Roitman
Journal:  J Neurosci       Date:  2013-01-09       Impact factor: 6.167

Review 6.  Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.

Authors:  Shitij Kapur
Journal:  Am J Psychiatry       Date:  2003-01       Impact factor: 18.112

7.  The nature of dopamine dysfunction in schizophrenia and what this means for treatment.

Authors:  Oliver D Howes; Joseph Kambeitz; Euitae Kim; Daniel Stahl; Mark Slifstein; Anissa Abi-Dargham; Shitij Kapur
Journal:  Arch Gen Psychiatry       Date:  2012-08

8.  Dopamine and the aberrant salience hypothesis of schizophrenia.

Authors:  Oliver D Howes; Matthew M Nour
Journal:  World Psychiatry       Date:  2016-02       Impact factor: 49.548

9.  Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release.

Authors:  Anne S Berry; Vyoma D Shah; Daniella J Furman; Robert L White; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Mark D'Esposito; William J Jagust
Journal:  Neuropsychopharmacology       Date:  2017-08-17       Impact factor: 7.853
  9 in total
  3 in total

1.  Dopamine and glutamate in individuals at high risk for psychosis: a meta-analysis of in vivo imaging findings and their variability compared to controls.

Authors:  Robert A McCutcheon; Kate Merritt; Oliver D Howes
Journal:  World Psychiatry       Date:  2021-10       Impact factor: 79.683

2.  Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [11C]-(+)-PHNO PET with methylphenidate challenge study.

Authors:  Ragy R Girgis; Mark Slifstein; Gary Brucato; Lawrence S Kegeles; Tiziano Colibazzi; Jeffrey A Lieberman; Anissa Abi-Dargham
Journal:  Mol Psychiatry       Date:  2020-11-05       Impact factor: 13.437

3.  Dopaminergic organization of striatum is linked to cortical activity and brain expression of genes associated with psychiatric illness.

Authors:  Robert A McCutcheon; Kirsten Brown; Matthew M Nour; Stephen M Smith; Mattia Veronese; Fernando Zelaya; Martin Osugo; Sameer Jauhar; William Hallett; Mitul M Mehta; Oliver D Howes
Journal:  Sci Adv       Date:  2021-06-09       Impact factor: 14.136
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.